|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/00 | |
| A61K 49/00 | |||
| A61P 35/00 | |||
| A61K 39/395 |
| (11) | Number of the document | 2155786 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08759012.1 |
| Date of filing the European patent application | 2008-06-04 | |
| (97) | Date of publication of the European application | 2010-02-24 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/004456 |
| Date | 2008-06-04 |
| (87) | Number | WO 2008/148546 |
| Date | 2008-12-11 |
| (30) | Number | Date | Country code |
| 07011087 | 2007-06-06 | EP |
| (72) |
HASMANN, Max, DE
LENZ, Helmut, DE
SCHEUER, Werner, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstra e 124, 4070 Basel,
CH
|
| (54) | COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL |
| COMPOSITION OF A FIRST NON-LABELED MONOCLONAL ANTIBODY BINDING TO A TUMOR ANTIGEN AND A NON-CROSS REACTIVE SECOND MONOCLONAL ANTIBODY LABELED WITH A NIR FLUORESCENCE LABEL |